Last reviewed · How we verify

NCT05838222

Integrating Solution Focused Interventions in Integrated Care

Completed NA Last updated 18 October 2023
What this trial tests

NA trial testing Solution Focused Intervention in Depression in 80 participants. Completed in 2 October 2023.

Timeline
8 May 2023
Primary endpoint
11 August 2023
2 October 2023

Quick facts

Lead sponsorUniversity of Georgia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment80
Start date8 May 2023
Primary completion11 August 2023
Estimated completion2 October 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Georgia

Who can join

18 and older, any sex, with Depression or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Integrated behavioral healthcare (IBH) emerged to address the high prevalence of psychosocial issues endemic to primary care settings coupled with primary care provider's discomfort in addressing psychosocial issues. IBH addresses the lack of psychosocial care in primary care settings by expanding the traditional healthcare team through the inclusion of a behavioral health provider (clinical social worker, licensed psychologist, etc.). The behavioral health provider utilizes evidenced based interventions to support the healthcare team with addressing a wide range of healthcare concerns. Solution Focused Brief Therapy (SFBT) provides a promising treatment approach within IBH settings due to the high productivity standards within primary care and the efficient, solution based style foundational to SFBT. In addition, SFBT is strengths based and emphasizes patient centered approaches which primary care aspires to achieve. Despite the natural fit, there is a paucity of research regarding SFBT within integrated care settings in general, and for specific disease states. The purpose of this study is to assess the efficacy of SFBT within an IBH setting in the treatment of depression while assessing for commensurate improvement with traditional healthcare markers such as A1C, blood pressure, pulse, and weight. In addition, scaling questions will be utilized to assess for increase in core SFBT constructs to include self-awareness of strengths, future hope, and increased ability to problem solve. A pre-posttest experimental design will assess the differences between those receiving SFBT and treatment as usual across symptoms of depression, SFBT core attributes, and health outcomes.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Addressing depression and comorbid health conditions through solution-focused brief therapy in an integrated care setting: a randomized clinical trial.
    Cooper ZW, Mowbray O, Ali MK, Johnson LCM. · · 2024 · cited 4× · PMID 39179982 · DOI 10.1186/s12875-024-02561-8
  2. Strategies for Fidelity Monitoring a Solution-Focused Brief Intervention in a Randomized Clinical Trial.
    Cooper ZW, Johnson L. · · 2025 · cited 1× · PMID 39873935 · DOI 10.1007/s10880-025-10063-7
  3. Strategies for Fidelity Monitoring a Solution-Focused Brief Intervention in a Randomized Clinical Trial
    Cooper Z, Johnson L. · · 2024 · DOI 10.21203/rs.3.rs-4085224/v1
  4. Addressing Depression and Comorbid Health Conditions through Solution-Focused Brief Therapy in an Integrated Care Setting: A Randomized Clinical Trial
    Cooper Z, Mowbray O, Ali M, Johnson L. · · 2024 · DOI 10.21203/rs.3.rs-3996940/v1

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other University of Georgia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing